USE OF 2-METHYLENE-19-NOR-(20S)-1ALPHA,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM IN PATIENTS PREVIOUSLY TREATED WITH CALCIMIMETICS - diagram, schematic, and image 07

Back to USE OF 2-METHYLENE-19-NOR-(20S)-1ALPHA,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM IN PATIENTS PREVIOUSLY TREATED WITH CALCIMIMETICS , All Patents .